2023 MD Anderson Hematology And Medical Oncology Board Review

YOU WILL GET THE COURSE VIA LIFETIME DOWNLOAD LINK (FAST SPEED) AFTER PAYMENT

85 MP4 + 118 PDF Files

The 2023 MD Anderson Cancer Center/Baylor College of Medicine Hematology and Medical Oncology Board Review

Conference Date: September 25, 2023 – September 30, 2023

Overview

This program should be of interest to Physicians, Advanced Practice Providers, APNs, and Nurses.

Objectives

1. Apply knowledge gained to prepare for the hematology and medical oncology subspecialty and recertification examinations in hematology and medical oncology;
2. Utilize current standards of care for patients with cancer, blood disorders and malignancies;
3. Demonstrate proficiency of knowledge in hematology and medical oncology;
4. Incorporate recent advances in management of hematologic and oncologic patients; and
5. Define molecular determinants of cancer risk and apply this knowledge in practice.

Program

• Benign Hematology Session
• Malignant Hematology Session
• Solid Tumor Session

Topics And Speakers:

AGENDA
Monday, September 25, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
BENIGN HEMATOLOGY SESSION
General Topics/Red Cell Disorders/Platelets
7:30 Iron Deficiency and Hemochromatosis
Matthew Heeney, MD
8:15 Hematopoietic Growth Factors
Martha Mims, MD, PhD
9:00 Bone Marrow Failure
Timothy Olson, MD, PhD
9:45 Break
10:00 Leukopenia and Leukocytosis
Nancy Berliner, MD
10:45 Issues in Transfusion Medicine
Kerry O’Brien, MD
11:45 Q & A Panel Discussion
Matthew Heeney, MD; Martha Mims, MD, PhD; Timothy Olson, MD, PhD;
Nancy Berliner, MD; and Kerry O’Brien, MD
12:00 pm Lunch
Coagulation/Platelets/Red Cell Disorders
12:30 Sickle Cell Anemias, Thalassemia, and Hemoglobinopathies
Alice Ma, MD
1:15 Hemolytic Anemias
Iberia Romina Sosa, MD, PhD
2:00 Approach to Anemia
Alice Ma, MD
2:30 Break
2:45 Disorders of Platelet Function
A. Koneti Rao, MD, FACP
3:30 Thrombocytopenias
Alvin Schmaier, MD
4:15 Q & A Panel Discussion
Alice Ma, MD; Iberia Romina Sosa, MD, PhD; A. Koneti Rao, MD, FACP;
and Alvin Schmaier, MD
4:30 Adjourn
Tuesday, September 26, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
Platelet/Red Cell Disorders/Transfusion Medicine
7:30 Antithrombotic & Antiplatelet Therapy
Alvin Schmaier, MD
8:15 Normal Coagulation
Kenneth Bauer, MD
9:00 Break
9:15 Coagulation Factor Deficiencies, Including von Willebrand’s Disease and
Hemophilias
Kenneth Bauer, MD
10:00 Hypercoagulable States
Stephan Moll, MD
11:00 Q & A Panel Discussion
Alvin Schmaier, MD; Kenneth Bauer, MD; and Stephan Moll, MD
11:15 Benign Hematology Q & A Session
Senthil Sukumar, MD
12:00 pm Lunch
MALIGNANT HEMATOLOGY SESSION
Lymphoma/Myeloma
12:30 Classification of Lymphoma
Lynne Abruzzo, MD, PhD
1:15 Aggressive Non‐Hodgkin Lymphoma
Loretta Nastoupil, MD
2:00 Indolent Non‐Hodgkin Lymphoma
Christopher Flowers, MD
2:45 Break
3:00 Hodgkin Lymphoma
TBD , MD
3:45 Multiple Myeloma and Other Plasma Cell Dyscrasias
S. Vincent Rajkumar, MD
4:45 Q & A Panel Discussion
Lynne Abruzzo, MD, PhD; Loretta Nastoupil, MD; Christopher Flowers, MD; and S.
Vincent Rajkumar, MD, PhD
5:00
Adjourn
Wednesday, September 27, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
MPN/CLL/SCT
7:30 Myeloproliferative Neoplasms
Raajit Rampal, MD
8:30 Chronic Lymphocytic Leukemia and Hairy Cell Leukemia
Susan O’Brien, MD
9:15 Break
9:30 Stem Cell Transplant Supportive Care
Betty Hamilton, MD
10:30 Q & A Panel Discussion
Raajit Rampal, MD; Susan O’Brien, MD; and Betty Hamilton, MD
10:45 Malignant Hematology Q & A Session
Kelly Chien, MD
11:25 Lunch Break
Leukemia/MDS
12:00 pm Chronic Myeloid Leukemia
Jorge Cortes, MD
12:45 Myelodysplastic Syndrome
Tapan Kadia, MD
1:45 Acute Myeloid Leukemia
Courtney DiNardo, MD
2:30 Break
2:45 Acute Lymphoblastic Leukemia
Hagop Kantarjian, MD
3:30 Infectious Complications in Cancer Patients
Samuel Shelburne, MD, PhD
4:15 Q & A Panel Discussion
Jorge Cortes, MD; Tapan Kadia, MD; Courtney DiNardo, MD, Hagop Kantarjian, MD;
and Samuel Shelburne, MD
4:30 Adjourn
Thursday, September 28, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
SOLID TUMOR SESSION
Pharmacology/Genetic Risk Factors/Sarcoma
7:30 Pharmacology I: Chemotherapy
Claire Mach, PharmD
8:30 Pharmacology II: Targeted Therapy (Alk, EGFR, VEGR, HER2, HH, mTOR, PARP)
Whitney Lewis, PharmD
9:00 Break
9:15 Pharmacology III: Targeted Therapy (CD20, CD30, CD33, Proteasome, BCR‐ABL/KIT, FLT3,
IDH1/2, CDK4/6, PI3K)
Brian Primeaux, PharmD
9:45 Pharmacology IV: Immunotherapy
Claire Mach, PharmD
10:05 Break
10:15 Genetic Risk Factors
Claudine Isaacs, MD
11:00 Sarcoma
Shreyaskumar Patel, MD
12:00 Q & A Panel Discussion
Claire Mach, PharmD; Whitney Lewis, PharmD; Brian Primeaux, PharmD;
Claudine Isaacs, MD; Shreyaskumar Patel, MD
12:15 pm Lunch Break
Breast Cancer
12:45 Screening/Local Management of Breast Cancer
Abenaa Brewster, MD
1:30 Systemic Treatment of Primary Breast Cancer Including HER2 Positive Breast Disease
Lisa Carey, MD
2:30 Break
2:45 Treatment of Metastatic Breast Cancer Including HER2 Positive Breast Disease
Mariana Chavez MacGregor, MD
3:45 Special Issues in Breast Cancer
Jennifer Litton, MD
4:15 Q & A Panel Discussion
Abenaa Brewster, MD; Lisa Carey, MD; Mariana Chavez MacGregor, MD;
and Jennifer Litton MD
4:30 ASH/ASCO Choosing Wisely Recommendations
Ravin Garg, MD
5:10 Adjourn
Friday, September 29, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
Lung Cancer/Head and Neck Cancer/Thyroid Cancer
7:30 Early Stage and Locally Advanced Non‐Small Cell Lung Cancer
Nasser Hanna, MD
8:15 Metastatic Non‐Small Cell Lung Cancer
Nasser Hanna, MD
9:15 Small Cell Lung Cancer
Carl Gay, MD
9:45 Break
10:00 Head and Neck Cancer
William N. William, Jr., MD
10:45 Thyroid Cancer
Mimi Hu, MD
11:15 Q & A Panel Discussion
Nasser Hanna, MD; Carl Gay, MD; William N. William, Jr., MD; and Mimi Hu, MD
11:30 Solid Tumor Q & A ‐ Session 1:
Breast Cancer/Lung Cancer/Head and Neck Cancer/Thyroid Cancer
Megan Dupuis, MD
12:10 pm Lunch Break
Gastrointestinal Oncology
12:45 Pancreaticobiliary Cancers/Unknown Primary
Robert Wolff, MD
1:45 Gastroesophageal Cancers/ Hepatocellular Carcinoma
Harry Yoon, MD
2:45 Break
3:00 Colorectal Cancer: Biology and Adjuvant Therapy
Scott Kopetz, MD, PhD
3:30 Metastatic Colorectal Cancer and Anal Cancer
Scott Kopetz, MD, PhD
4:30 Q & A Panel Discussion
Robert Wolff, MD; Harry Yoon, MD; and Scott Kopetz, MD, PhD
4:45 Solid Tumor Q & A ‐ Session 2: Pharmacology/Genetic Risk Factors/Sarcoma/GI
Mark Lewis, MD
5:10 Adjourn
Saturday, September 30, 2023
All time is Central Standard Time (CST)
7:00 am Virtual On‐line Registration Check‐in
Genitourinary Oncology/Melanoma
7:30 Testicular Cancer
Timothy Gilligan, MD
8:30 Urothelial Cancer
Arlene Siefker‐Radtke, MD
9:15 Renal Cell Carcinoma
Eric Jonasch, MD
10:00 Break
10:15 Prostate Cancer
Brad Carthon, MD
11:15 Melanoma
Rodabe Amaria, MD
12:00 pm Q & A Panel Discussion
Timothy Gilligan, MD; Arlene Siefker‐Radtke, MD; Eric Jonasch, MD;
Brad Carthon, MD; and Rodabe Amaria, MD
12:15 Lunch
Neuro‐Onc/Gynecologic Oncology
1:00 Neuro‐Oncology
Antonio Omuro, MD
1:45
Cervical Cancer
Alejandro Rauh Hain, MD
2:30 Break
2:45 Uterine Cancer
Shannon Westin, MD
3:15 Ovarian Cancer and Unusual Ovarian Histologies
Shannon Westin, MD
4:15 Q & A Panel Discussion
Antonio Omuro, MD; Alejandro Rauh Hain, MD; and Shannon Westin, MD
4:30 Solid Tumor Q & A – Session 3:
Genitourinary/Melanoma/Neuro‐Oncology/Gyn Onc
Ravin Garg, MD
5:10 Adjourn